FREDUN PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of FREDUN PHARMACEUTICALS have increased by 22.37% YoY .
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 39.47 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
FREDUN PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539730]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹275 Cr | ₹224 Cr | ₹134 Cr | ₹11,277,136 Cr | ₹97 Cr |
| Expenses | ₹247 Cr | ₹211 Cr | ₹125 Cr | ₹10,444,052 Cr | ₹87 Cr |
| Operating Profit (Excl OI) | ₹28 Cr | ₹14 Cr | ₹9.35 Cr | ₹833,084 Cr | ₹10 Cr |
| Other Income | ₹1.82 Cr | ₹1.63 Cr | ₹1.40 Cr | ₹51,713 Cr | ₹0.58 Cr |
| Interest | ₹9.28 Cr | ₹4.78 Cr | ₹4.37 Cr | ₹447,457 Cr | ₹3.12 Cr |
| Depreciation | ₹2.81 Cr | ₹2.16 Cr | ₹2.00 Cr | ₹187,873 Cr | ₹1.33 Cr |
| Profit Before Tax | ₹18 Cr | ₹8.60 Cr | ₹3.21 Cr | ₹249,467 Cr | ₹6.16 Cr |
| Profit After Tax | ₹11 Cr | ₹6.34 Cr | ₹2.02 Cr | ₹190,192 Cr | ₹4.46 Cr |
| Earnings Per Share (Rs) | ₹33.25 | ₹23.84 | ₹14.29 | ₹5.05 | ₹4.77 |
| PAT Margin (%) | 4.49 | 3.93 | 2.82 | 1.50 | 1.69 |
| ROE(%) | 15.03 | 13.86 | 11.42 | 4.77 | 4.74 |
| ROCE(%) | 17.13 | 17.64 | 13.15 | 9.53 | 10.36 |
| Total Debt/Equity(x) | 0.88 | 0.98 | 0.78 | 0.92 | 0.84 |
Key Financials |
||
| Market Cap | : | ₹ 331.9 Cr |
| Revenue (TTM) | : | ₹ 406.9 Cr |
| Net Profit(TTM) | : | ₹ 18.8 Cr |
| EPS (TTM) | : | ₹ 40.0 |
| P/E (TTM) | : | 17.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FREDUN PHARMACEUTICALS | 5.6% | 5.9% | -18.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
| DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
| CIPLA | -1.8% | 1% | 0.5% |
| TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
| DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
| MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
| ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
| LUPIN | -2.7% | 1% | 30.1% |
FREDUN PHARMACEUTICALS Revenues
[BOM: 539730]
| Y-o-Y | 22.37 % |
| 5 Yr CAGR | 29.72 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹275 Cr | 22.37 | |
| Mar2023 | ₹224 Cr | 67.64 | |
| Mar2022 | ₹134 Cr | -100.00 | |
| Mar2021 | ₹11,277,136 Cr | 11,623,895.95 | |
| Mar2020 | ₹97 Cr | - | |
FREDUN PHARMACEUTICALS Operating Profit
[BOM: 539730]
| Y-o-Y | 99.68 % |
| 5 Yr CAGR | 29.00 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹28 Cr | 99.68 | |
| Mar2023 | ₹14 Cr | 48.83 | |
| Mar2022 | ₹9.35 Cr | -100.00 | |
| Mar2021 | ₹833,084 Cr | 8,305,822.00 | |
| Mar2020 | ₹10 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 63.06 % |
| 5 Yr CAGR | -0.56 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 10.11% | 63.06 | |
| Mar2023 | 6.2% | -11.17 | |
| Mar2022 | 6.98% | -5.55 | |
| Mar2021 | 7.39% | -28.53 | |
| Mar2020 | 10.34% | - | |
FREDUN PHARMACEUTICALS Profit After Tax
[BOM: 539730]
| Y-o-Y | 70.59 % |
| 5 Yr CAGR | 24.76 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹11 Cr | 70.59 | |
| Mar2023 | ₹6.34 Cr | 214.39 | |
| Mar2022 | ₹2.02 Cr | -100.00 | |
| Mar2021 | ₹190,192 Cr | 4,264,291.03 | |
| Mar2020 | ₹4.46 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 14.25 % |
| 5 Yr CAGR | 27.67 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 4.49 % | 14.25 | |
| Mar2023 | 3.93 % | 39.36 | |
| Mar2022 | 2.82 % | 88.00 | |
| Mar2021 | 1.5 % | -11.24 | |
| Mar2020 | 1.69 % | - | |
FREDUN PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539730]
| Y-o-Y | 39.47 % |
| 5 Yr CAGR | 62.49 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹33 | 39.47 | |
| Mar2023 | ₹24 | 66.83 | |
| Mar2022 | ₹14 | 182.97 | |
| Mar2021 | ₹5.05 | 5.87 | |
| Mar2020 | ₹4.77 | - | |
FREDUN PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539730]
| Y-o-Y | -2.89 % |
| 5 Yr CAGR | 13.40 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 17.13% | -2.89 | |
| Mar2023 | 17.64% | 34.14 | |
| Mar2022 | 13.15% | 37.99 | |
| Mar2021 | 9.53% | -8.01 | |
| Mar2020 | 10.36% | - | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹706.2 |
| Current MarketCap | : | ₹ 331.9 Cr |
| Updated EOD on | : | Apr 04,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 5.6% |
5.9% |
-18.1% |
| SENSEX | -2.9% |
3.1% |
1.8% |
FREDUN PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about FREDUN PHARMACEUTICALS Financials
How the annual revenues of FREDUN PHARMACEUTICALS have changed ?
The Revenues of FREDUN PHARMACEUTICALS have increased by 22.37% YoY .
How the Earnings per Share (EPS) of FREDUN PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 39.47 % YoY .
Check out Intrinsic Value of Peers of FREDUN PHARMACEUTICALS
Compare Stock Analytics of Peers of FREDUN PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
